# Early Administration of Prothrombin Concentrate Complex in Patients With Acute Hemorrhage Following Severe Trauma

> **NCT03218722** · PHASE3 · COMPLETED · sponsor: **University Hospital, Grenoble** · enrollment: 350 (actual)

## Conditions studied

- Shock, Hemorrhagic

## Interventions

- **DRUG:** Pro-Thrombin Concentrate Complex
- **DRUG:** NaCl 0.9%

## Key facts

- **NCT ID:** NCT03218722
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-29
- **Primary completion:** 2021-08-31
- **Final completion:** 2022-06-15
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2022-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03218722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03218722, "Early Administration of Prothrombin Concentrate Complex in Patients With Acute Hemorrhage Following Severe Trauma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03218722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*